Clinical Trial Update: Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating berberine to prevent contrast-induced nephropathy in patients with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Diabetes Mellitus, Chronic Kidney Disease | Phase 4 | Status: COMPLETED